HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Kohei Kaku Selected Research
Kohei Kaku Research Topics
Disease
138
Type 2 Diabetes Mellitus (MODY)
04/2024 - 08/2002
24
Diabetes Mellitus
11/2023 - 08/2002
24
Hypoglycemia (Reactive Hypoglycemia)
12/2022 - 06/2010
23
Body Weight (Weight, Body)
03/2024 - 06/2004
21
Insulin Resistance
03/2024 - 03/2005
15
Hyperglycemia
01/2023 - 07/2013
14
Type 1 Diabetes Mellitus (Autoimmune Diabetes)
11/2022 - 01/2009
13
Atherosclerosis
03/2024 - 04/2010
8
Neoplasms (Cancer)
01/2023 - 01/2016
8
Weight Loss (Weight Reduction)
09/2021 - 01/2019
8
Diabetic Nephropathies (Diabetic Nephropathy)
09/2019 - 08/2002
7
Infections
10/2022 - 10/2018
6
Obesity
03/2024 - 04/2016
6
Hypertension (High Blood Pressure)
09/2023 - 11/2011
6
Drug-Related Side Effects and Adverse Reactions
07/2023 - 09/2016
6
Edema (Dropsy)
09/2022 - 01/2009
6
Weight Gain
09/2021 - 01/2009
6
Glucose Intolerance
03/2015 - 08/2008
5
Inflammation (Inflammations)
03/2024 - 01/2019
5
Urinary Tract Infections (Urinary Tract Infection)
07/2023 - 10/2017
5
Hypertriglyceridemia
07/2023 - 11/2007
5
Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 04/2010
4
Fatty Liver
03/2024 - 07/2016
4
Pain (Aches)
12/2023 - 01/2016
4
Dyslipidemias (Dyslipidemia)
09/2023 - 08/2019
4
Hypothyroidism
01/2023 - 01/2022
4
Cushing Syndrome
10/2022 - 01/2017
4
Diabetic Ketoacidosis (Ketoacidosis, Diabetic)
10/2022 - 02/2020
4
Graves Disease (Basedow Disease)
09/2022 - 12/2016
4
Carotid Artery Diseases
02/2019 - 11/2010
3
Chronic Renal Insufficiency
11/2023 - 06/2021
3
Hypophosphatemia
12/2022 - 01/2016
3
Diabetes Complications
10/2022 - 01/2022
3
Hypersensitivity (Allergy)
10/2022 - 01/2009
3
Diabetic Neuropathies (Diabetic Neuropathy)
01/2022 - 05/2015
3
Heart Failure
01/2022 - 01/2017
3
Arteriosclerosis
07/2021 - 11/2017
3
Non-alcoholic Fatty Liver Disease
06/2021 - 01/2019
Drug/Important Bio-Agent (IBA)
57
Glucose (Dextrose)
FDA Link
Generic
03/2024 - 06/2004
51
Insulin (Novolin)
FDA Link
04/2024 - 08/2008
27
Hypoglycemic Agents (Hypoglycemics)
IBA
11/2023 - 01/2009
21
6- ((4- ethylphenyl)methyl)- 3',4',5',6'- tetrahydro- 6'- (hydroxymethyl)spiro(isobenzofuran- 1(3H),2'- (2H)pyran)- 3',4',5'- triol
IBA
11/2023 - 03/2014
20
Sodium-Glucose Transporter 2 Inhibitors
IBA
03/2024 - 11/2013
18
Sodium
IBA
07/2023 - 07/2013
12
Lipids
IBA
11/2023 - 08/2002
12
Sodium-Glucose Transport Proteins
IBA
01/2020 - 04/2014
11
Dipeptidyl-Peptidase IV Inhibitors
IBA
03/2024 - 02/2014
11
Blood Glucose (Blood Sugar)
IBA
03/2024 - 09/2009
10
Pioglitazone (Actos)
FDA Link
11/2020 - 03/2005
9
Glycated Hemoglobin (Glycosylated Hemoglobin)
IBA
02/2021 - 06/2012
8
empagliflozin
IBA
07/2023 - 01/2017
8
Incretins
IBA
03/2022 - 07/2013
8
insulin degludec
IBA
03/2022 - 01/2013
8
trelagliptin
IBA
03/2020 - 02/2014
8
Liraglutide
FDA Link
12/2019 - 08/2011
7
Glucagon-Like Peptide-1 Receptor
IBA
01/2024 - 11/2017
7
Hydrocortisone (Cortisol)
FDA Link
Generic
01/2023 - 01/2015
7
ipragliflozin
IBA
12/2021 - 07/2018
7
Sitagliptin Phosphate (Januvia)
FDA Link
01/2021 - 11/2013
7
alogliptin
IBA
11/2019 - 09/2011
6
Adrenocorticotropic Hormone (ACTH)
FDA Link
01/2023 - 01/2015
6
Antibodies
IBA
01/2023 - 04/2019
5
1,5- anhydro- 1- (5- (4- ethoxybenzyl)- 2- methoxy- 4- methylphenyl)- 1- thioglucitol
IBA
03/2024 - 01/2015
5
imeglimin
IBA
03/2024 - 01/2022
5
Transcription Factors (Transcription Factor)
IBA
01/2023 - 01/2005
5
Thyrotropin (Thyroid-Stimulating Hormone)
FDA Link
01/2023 - 01/2021
5
Symporters
IBA
01/2022 - 12/2014
5
Glucagon-Like Peptide 1 (GLP 1)
IBA
07/2021 - 08/2011
5
Metformin (Glucophage)
FDA Link
Generic
03/2021 - 05/2009
5
voglibose (Basen)
IBA
06/2014 - 05/2009
4
Lipoproteins (Lipoprotein)
IBA
07/2023 - 08/2002
4
Cholesterol
IBA
01/2023 - 05/2009
4
Thyroxine (Levothyroxine)
FDA Link
Generic
01/2023 - 01/2021
4
C-Reactive Protein
IBA
09/2022 - 03/2016
4
Steroids
IBA
01/2022 - 01/2015
4
glimepiride (Amarel)
FDA Link
Generic
11/2020 - 12/2012
4
Adiponectin
IBA
11/2020 - 05/2009
4
Canagliflozin
IBA
01/2020 - 12/2015
4
Insulin Glargine (Lantus)
FDA Link
01/2018 - 01/2013
4
mitiglinide
IBA
06/2014 - 01/2009
4
Rosuvastatin Calcium (Crestor)
FDA Link
01/2014 - 04/2010
3
C-Peptide
IBA
04/2024 - 08/2008
3
Apolipoproteins E (ApoE)
IBA
03/2024 - 08/2002
3
Biomarkers (Surrogate Marker)
IBA
03/2024 - 06/2016
3
Hemoglobins (Hemoglobin)
IBA
03/2024 - 11/2016
3
semaglutide
IBA
01/2024 - 01/2018
3
dulaglutide
IBA
01/2024 - 01/2021
3
Apolipoproteins
IBA
12/2023 - 08/2002
3
Enzymes
IBA
11/2023 - 07/2013
3
Hormones (Hormone)
IBA
01/2023 - 01/2015
3
Immune Checkpoint Inhibitors
IBA
01/2023 - 01/2021
3
Thyroid Hormones
IBA
01/2023 - 01/2022
3
Proteins (Proteins, Gene)
FDA Link
12/2022 - 01/2005
3
Anti-Bacterial Agents (Antibiotics)
IBA
07/2021 - 01/2019
3
Triglycerides (Triacylglycerol)
IBA
06/2021 - 01/2016
3
Nonesterified Fatty Acids (NEFA)
IBA
01/2020 - 05/2009
Therapy/Procedure
69
Therapeutics
04/2024 - 01/2009
39
Glycemic Control
03/2024 - 01/2009
5
Exercise Therapy (Therapy, Exercise)
03/2020 - 11/2011
3
Renal Dialysis (Hemodialysis)
03/2020 - 01/2016